Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stress.

Solid tumors arise within hostile microenvironments shaped by hypoxia, nutrient deprivation, acidosis, mechanical stress, immune pressure, and therapy-induced insults. Beyond malignant cells, stromal and immune components, including cancer-associated fibroblasts, endothelial cells, and infiltrating leukocytes, co-evolve with tumor cells to regulate tumor initiation, progression, and therapeutic response. Rather than passively tolerating stress, tumor cells actively reprogram signaling and transcriptional networks, frequently through the induction of stress-responsive membrane proteins. These proteins are typically low or absent under homeostatic conditions but are upregulated by hypoxic, metabolic, inflammatory, or therapeutic stress. By coordinating nutrient uptake, metabolite exchange, cell-matrix interactions, survival signaling, invasion, and immune evasion, stress-responsive membrane proteins function as critical execution nodes that support tumor stress tolerance and evolutionary fitness. In this Review, we summarize major microenvironmental stresses in solid tumors, delineate membrane protein-mediated stress-adaptation mechanisms, and discuss clinically approved and emerging strategies targeting stress-responsive membrane proteins to enhance treatment efficacy and overcome therapeutic resistance.